neurons.bio

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Decode Health is an AI and analytics platform that accelerates precision healthcare by supporting healthcare teams in launching machine learning and advanced analytics projects. The platform collaborates with pharmaceutical companies to enhance patient selection, biomarker identification, diagnostics development, data asset creation, and analysis. Decode Health offers modules for biomarker discovery, patient recruitment, next-generation sequencing, data analysis, and clinical decision support. The platform aims to provide fast, accurate, and actionable insights for acute and chronic disease management. Decode Health's custom-built modules are designed to work together to solve complex data problems efficiently.

Dimensions AI is an advanced scientific research database that provides a suite of research applications and time-saving solutions for intelligent discovery and faster insight. It hosts the largest collection of interconnected global research data, including publications, clinical trials, patents, policy documents, grants, datasets, and online citations. The platform offers easy-to-understand visualizations, purpose-built applications, and integrated AI technology to speed up research interpretation and analysis. Dimensions is designed to propel research by connecting the dots across the research ecosystem and saving researchers hours of time.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

DrugCard is an AI-enabled Data Intelligence platform designed to streamline drug safety routines, particularly in pharmacovigilance. It offers solutions for local literature screening, catering to CROs, MAHs, and freelancers in the pharmaceutical industry. The platform supports multiple languages, covers various medical journals, and saves significant time compared to manual approaches. DrugCard aims to enhance pharmacovigilance processes by leveraging AI, automation, and traceability to meet regulatory requirements and improve screening results.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop innovative medicines with exceptional potency and selectivity. The platform, known as GEMS (Generative AI for Drug Discovery), combines AI and physics research to identify drug candidates against challenging targets at an accelerated pace. The company's approach involves designing highly potent and selective drugs for chemically complex targets, driven by a team of collaborative minds across AI and biotech disciplines. Genesis Therapeutics is dedicated to advancing breakthrough medicines and bringing new hope to patients through its unique blend of technology and expertise.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Humbi AI is an AI-powered platform offering actuarial services for healthcare organizations, health plans, provider organizations, and drug manufacturers. The platform combines data science and actuarial expertise to provide competitive intelligence analytics, helping clients identify opportunities and manage risks effectively. Humbi AI offers a range of services from data management to actuarial design, incorporating knowledge from various fields such as medical science and technology. The platform includes tools for Medicare Advantage strategy building, provider performance comparison, pharmacy management, and access to medical and pharmacy data for millions of members.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Radiology Business is an AI tool designed to provide insights and solutions for professionals in the radiology field. The platform covers a wide range of topics including management, imaging, technology, and conferences. It offers news, analysis, and resources to help radiologists stay informed and make informed decisions. Radiology Business aims to leverage artificial intelligence to improve workflow efficiency and enhance the overall experience in the radiology ecosystem.

Medcol.io is a clinical AI assistant designed to support healthcare professionals in making informed decisions by providing evidence-based recommendations and insights. The platform leverages advanced algorithms and medical data analysis to assist in diagnosing diseases, suggesting treatment plans, and predicting patient outcomes. With a user-friendly interface and real-time updates, Medcol.io aims to streamline the clinical decision-making process and improve patient care.

CoFinance is an AI-driven legal intelligence and collaboration hub that revolutionizes legal and compliance research workflows. It combines semantic search, multi-faceted document analysis, and intelligent organization tools to provide precise and efficient research solutions. The platform leverages cutting-edge Regulatory Artificial Intelligence (RAI) technology to ensure that answers are sourced from real, authoritative data. CoFinance prioritizes simplifying regulatory complexity, mitigating compliance risks, accelerating research efficiency, and providing reliable partnership for long-term compliance success. It caters to organizations navigating complex regulatory landscapes, offering quick adaptation to changes and seamless compliance across various industries and jurisdictions.

BetterMedicine is an AI software designed for cancer diagnostics and detection. It offers AI-powered solutions to enhance patient outcomes and drive efficiency in radiology workflows. The software is expertly designed by medical professionals and AI specialists, providing trusted and clinically validated solutions. BetterMedicine aims to address inefficiencies in radiology by integrating AI-powered software for detecting lesions on CT scans seamlessly into the workflow, thereby improving efficiency and reducing the risk of oversight. The application focuses on improving patient outcomes, reducing errors, and enhancing the wellbeing of radiology professionals.

The website OpenLife.ai is an AI tool that focuses on various aspects of healthcare, including medical AI, ambient clinical intelligence, clinical documentation integrity, healthcare analytics, patient engagement, radiology solutions, and more. It offers insights, news, and resources related to the application of artificial intelligence in the healthcare industry.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

The website is a comprehensive platform offering a suite of software solutions for library management, research, teaching, and learning in the higher education ecosystem. It leverages generative AI, linked open data, and conversational discovery to optimize operations, integration, personalized experiences, and analytic insights. The platform includes various products and services such as Alma, Primo, Leganto, Rapido, Rosetta, and campusM, catering to the unique needs of academic institutions, libraries, and technology powerhouses. The website features success stories, customer testimonials, webinars, learning resources, and community engagement initiatives.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop innovative medicines with exceptional potency and selectivity. The platform, known as GEMS (Generative AI for Drug Discovery), combines AI and physics research to identify drug candidates against challenging targets at an accelerated pace. The company's approach involves designing highly potent and selective drugs for chemically complex targets, driven by a team of collaborative minds across AI and biotech disciplines. Genesis Therapeutics is dedicated to advancing breakthrough medicines and bringing new hope to patients through its unique blend of technology and expertise.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

Decode Health is an AI and analytics platform that accelerates precision healthcare by supporting healthcare teams in launching machine learning and advanced analytics projects. The platform collaborates with pharmaceutical companies to enhance patient selection, biomarker identification, diagnostics development, data asset creation, and analysis. Decode Health offers modules for biomarker discovery, patient recruitment, next-generation sequencing, data analysis, and clinical decision support. The platform aims to provide fast, accurate, and actionable insights for acute and chronic disease management. Decode Health's custom-built modules are designed to work together to solve complex data problems efficiently.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

LifeSciencesIntelligence is a comprehensive online platform that delivers the latest news, insights, and resources in the fields of life sciences, biotechnology, genetics/genomics, and pathology. It serves as a valuable hub for professionals, researchers, and industry experts to stay informed about cutting-edge advancements and emerging trends in these domains.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.